Literature DB >> 6749988

Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice.

R W Finley, L J Mackey, P H Lambert.   

Abstract

The course of lethal Plasmodium berghei infection was examined in nu/+ and T cell-deficient nu/nu BALB/c mice. A rapidly fatal neurologic syndrome, including ataxia, hemiparesis, and seizures, was seen in the nu/+ mice early in the infection, whereas this syndrome was absent in the nu/nu mice. The nu/nu mice also developed anemia more slowly, had lower levels of immune complexes and total IgG, and had smaller decreases in serum C3 compared with the nu/+ mice. Histopathologic examination of the brains revealed cerebral malaria lesions, including vascular plugging and micro-hemorrhages, in the nu/+ mice but not in the nu/nu mice. Cerebral lesions similar in frequency and severity to those in nu/+ mice developed in nu/nu mice given spleen cells from normal nu/+ mice. The results suggest that an intact immune system is necessary for the expression of cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749988

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

3.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.

Authors:  L A Sanni; S R Thomas; B N Tattam; D E Moore; G Chaudhri; R Stocker; N H Hunt
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 5.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

6.  Plasmodium berghei resists killing by reactive oxygen species.

Authors:  Peter Sobolewski; Irene Gramaglia; John A Frangos; Marcos Intaglietta; Henri van der Heyde
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls.

Authors:  K E Lyke; R Burges; Y Cissoko; L Sangare; M Dao; I Diarra; A Kone; R Harley; C V Plowe; O K Doumbo; M B Sztein
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria.

Authors:  Guang Sun; Wun-Ling Chang; Jie Li; Seth Mark Berney; Donald Kimpel; Henri C van der Heyde
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.